Polycystic Ovary Disease (PCOD)

Uploaded: 2008-07-04, Updated: 2008-07-04

 

DEFINITION

  • 2003 ESHRE/ASRM consensus: PCOD should meet two of the three criteria:

    1. Oligoovulation or anovulation;

    2. Excess androgen activity;

    3. Polycystic ovaries (by gynecologic ultrasound), and other endocrine disorders are excluded.

GENERAL FEATURES

  • Also known as Stein-Leventhal syndrome.

  • Most common hormonal disorder among women of reproductive age, affects 3-10%, leading cause of infertility.

  • Key components of PCOD: hyperandrogenism (especially testosterone), sustained LH levels (LH/FSH > 1:1), and hyperinsulinemia.

  • Common symptoms of PCOD

    • Oligomenorrhea, amenorrhea:  irregular, few, or absent menstrual periods.

    • Infertility: chronic anovulation.

    • Obesity: one of two women with PCOD are obese.

    • Hirsutism: excessive and increased body hair, typically in a male pattern affecting face, chest and legs.

    • Hair loss appearing as thinning hair on the top of the head

    • Acne, oily skin, seborrhea.

    • Insulin resistance.

    • Depression.

  • Risk of women with PCOD:

    • Endometrial hyperplasia and endometrial cancer: lack of progesterone resulting in prolonged stimulation of endometrium by estrogen.

    • Insulin resistance/Type II diabetes

    • High blood pressure

    • Dyslipidemia

    • Cardiovascular disease

    • Strokes

    • Weight gain

    • Miscarriage

PATHOGENESIS

  • Increases GnRH pulse frequency;

  • Excessive and more frequent release of LH by the anterior pituitary gland, and hyperinsulinemia;

  • Excessive production of androgens by ovarian theca cell, and excessive production of estrone by ovarian granulosa cells;

  • Decrease of follicular maturation and SHBG binding;

  • Development of PCOD, and endometrial hyperplasia.

GROSS FINDINGS

  • Enlarged ovaries with thickened and smooth outer surface; multiple blue, translucent subsurface cortical cysts;

  • On cut surface, multiple cysts are typically arranged in a radial fashion along the cortex with 1-2mm intervening dense fibrotic stroma.

MICROSCOPIC FINDINGS

  • Enlarged ovarian size (2-fold), including thickness of cortical and subcortical stroma;
  • Thickened collagenized tunia;
  • Normal number of primordial follicles;
  • Twice the number of ripening and atretic follicles;
  • Multiple follicular cysts (1-2mm) with luteinized theca layer (theca-lutein hyperplasia);
  • Minimal evidence of ovulation with rare or no recent or degenerating corpora lutea, increased numbers of hilus cells.
  • Often stromal hyperplasia with luteinized stromal cells (hyperthecosis).

TREATMENT

  • Lowering of insulin levels: weight loss, metformin.
  • Restoration of fertility: diet modification, weight loss, and treatment with metformin and clomiphene citrate.
  • Treatment of hirsutism or acne: contraceptive pill, spironolactone.
  • Restoration of regular menstruation, and prevention of endometrial hyperplasia and endometrial cancer.
  • Wedge resection.

REFERENCES

  • Diagnostic gynecologic and obstetric pathology. Christopher P. Crum and Kenneth R. Lee. 2006

  • http://www.emedicine.com/med/topic2173.htm